|
|
| G
|
Agt
|
angiotensinogen
|
multiple interactions
|
EXP
|
Plicamycin inhibits the reaction [AGT protein results in increased expression of TGFB1 mRNA]
|
CTD |
PMID:25398788 |
|
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
|
|
| G
|
Ankrd37
|
ankyrin repeat domain 37
|
decreases expression
|
EXP
|
Plicamycin results in decreased expression of ANKRD37 mRNA
|
CTD |
PMID:23814049 |
|
NCBI chr16:53,001,487...53,004,545
Ensembl chr16:52,994,740...53,004,545
|
|
| G
|
Atp7a
|
ATPase copper transporting alpha
|
multiple interactions decreases expression
|
EXP
|
Plicamycin inhibits the reaction [cobaltous chloride results in increased expression of ATP7A mRNA] Plicamycin results in decreased expression of ATP7A mRNA
|
CTD |
PMID:23814049 |
|
NCBI chr X:75,159,635...75,267,094
Ensembl chr X:75,159,782...75,267,093
|
|
| G
|
Axl
|
Axl receptor tyrosine kinase
|
decreases expression
|
ISO
|
Plicamycin results in decreased expression of AXL
|
CTD |
PMID:18522535 |
|
NCBI chr 1:90,392,864...90,424,123
Ensembl chr 1:90,392,864...90,424,009
|
|
| G
|
Bnip3l
|
BCL2 interacting protein 3 like
|
multiple interactions decreases expression
|
EXP ISO
|
Plicamycin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BNIP3L mRNA] Plicamycin results in decreased expression of BNIP3L mRNA
|
CTD |
PMID:16291751 |
|
NCBI chr15:45,350,081...45,373,213
Ensembl chr15:45,334,537...45,373,282
|
|
| G
|
Cdh1
|
cadherin 1
|
multiple interactions
|
ISO
|
Plicamycin inhibits the reaction [afimoxifene promotes the reaction [ESR1 protein binds to CDH1 promoter]]
|
CTD |
PMID:19593637 |
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
|
|
| G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
multiple interactions
|
ISO
|
Plicamycin inhibits the reaction [[Cyclosporine co-treated with NGF protein] results in increased expression of CDKN1A mRNA]; Plicamycin inhibits the reaction [SP1 protein binds to CDKN1A promoter]
|
CTD |
PMID:24244623 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
| G
|
Cybrd1
|
cytochrome b reductase 1
|
multiple interactions decreases expression
|
EXP
|
Plicamycin inhibits the reaction [cobaltous chloride results in increased expression of CYBRD1 mRNA] Plicamycin results in decreased expression of CYBRD1 mRNA
|
CTD |
PMID:23814049 |
|
NCBI chr 3:76,342,231...76,369,846
Ensembl chr 3:76,342,404...76,370,061
|
|
| G
|
Ddit4
|
DNA-damage-inducible transcript 4
|
multiple interactions
|
ISO
|
[Plicamycin results in decreased activity of SP1 protein] inhibits the reaction [cobaltous chloride results in increased expression of DDIT4 mRNA]; [Plicamycin results in decreased activity of SP1 protein] inhibits the reaction [cobaltous chloride results in increased expression of DDIT4 protein]
|
CTD |
PMID:17307335 |
|
NCBI chr20:28,434,938...28,437,037
Ensembl chr20:28,434,944...28,437,037
|
|
| G
|
Epas1
|
endothelial PAS domain protein 1
|
decreases expression
|
EXP
|
Plicamycin results in decreased expression of EPAS1 mRNA
|
CTD |
PMID:23814049 |
|
NCBI chr 6:13,543,252...13,626,147
Ensembl chr 6:13,544,389...13,624,729
|
|
| G
|
Ern1
|
endoplasmic reticulum to nucleus signaling 1
|
multiple interactions
|
ISO
|
Plicamycin inhibits the reaction [Butyric Acid results in increased expression of ERN1 protein]
|
CTD |
PMID:26784903 |
|
NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,830,428...91,920,791
|
|
| G
|
Esr1
|
estrogen receptor 1
|
multiple interactions
|
ISO
|
Plicamycin inhibits the reaction [afimoxifene promotes the reaction [ESR1 protein binds to CDH1 promoter]]
|
CTD |
PMID:19593637 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
F3
|
coagulation factor III, tissue factor
|
multiple interactions decreases expression
|
ISO
|
Plicamycin inhibits the reaction [Asbestos results in increased expression of F3 mRNA] Plicamycin results in decreased expression of F3 mRNA
|
CTD |
PMID:15636197 |
|
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369
|
|
| G
|
Gata4
|
GATA binding protein 4
|
decreases expression
|
ISO
|
Plicamycin results in decreased expression of GATA4 protein
|
CTD |
PMID:34087332 |
|
NCBI chr15:41,635,572...41,707,252
Ensembl chr15:41,635,572...41,681,609
|
|
| G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
multiple interactions
|
ISO
|
Plicamycin inhibits the reaction [Butyric Acid results in increased expression of HSPA5 protein]
|
CTD |
PMID:26784903 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
| G
|
Ifng
|
interferon gamma
|
multiple interactions
|
ISO
|
Plicamycin inhibits the reaction [IFNG protein promotes the reaction [decitabine results in increased expression of PLA2G2A protein]]
|
CTD |
PMID:18953428 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
| G
|
Maoa
|
monoamine oxidase A
|
multiple interactions
|
ISO
|
Plicamycin inhibits the reaction [Dexamethasone results in increased expression of MAOA mRNA]
|
CTD |
PMID:15946989 |
|
NCBI chr X:8,615,239...8,681,372
Ensembl chr X:8,615,239...8,682,631
|
|
| G
|
Ngf
|
nerve growth factor
|
multiple interactions
|
ISO
|
Plicamycin inhibits the reaction [[Cyclosporine co-treated with NGF protein] results in increased expression of CDKN1A mRNA]
|
CTD |
PMID:24244623 |
|
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834
|
|
| G
|
Pfkp
|
phosphofructokinase, platelet
|
decreases expression
|
ISO
|
Plicamycin results in decreased expression of PFKP mRNA
|
CTD |
PMID:34087332 |
|
NCBI chr17:68,639,749...68,704,055
Ensembl chr17:68,639,481...68,705,752
|
|
| G
|
Pla2g2a
|
phospholipase A2 group IIA
|
multiple interactions
|
ISO
|
Plicamycin inhibits the reaction [IFNG protein promotes the reaction [decitabine results in increased expression of PLA2G2A protein]]
|
CTD |
PMID:18953428 |
|
NCBI chr 5:156,359,725...156,362,302
Ensembl chr 5:156,359,725...156,362,297
|
|
| G
|
Pon1
|
paraoxonase 1
|
multiple interactions
|
ISO
|
Plicamycin inhibits the reaction [pitavastatin results in increased expression of PON1 mRNA]
|
CTD |
PMID:15690306 |
|
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:34,261,289...34,287,924
|
|
| G
|
Pon2
|
paraoxonase 2
|
multiple interactions
|
ISO
|
Plicamycin inhibits the reaction [Chlorpyrifos results in increased expression of PON2 mRNA]
|
CTD |
PMID:24979751 |
|
NCBI chr 4:34,356,270...34,391,684
Ensembl chr 4:34,356,274...34,391,996
|
|
| G
|
Ppard
|
peroxisome proliferator-activated receptor delta
|
multiple interactions
|
ISO
|
Plicamycin inhibits the reaction [PPARD protein results in increased expression of SIRT1 mRNA]
|
CTD |
PMID:20160399 |
|
NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,352,183...6,365,707
|
|
| G
|
Sirt1
|
sirtuin 1
|
multiple interactions
|
ISO
|
Plicamycin inhibits the reaction [PPARD protein results in increased expression of SIRT1 mRNA]
|
CTD |
PMID:20160399 |
|
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000
|
|
| G
|
Slc11a2
|
solute carrier family 11 member 2
|
multiple interactions decreases expression
|
EXP
|
Plicamycin inhibits the reaction [cobaltous chloride results in increased expression of SLC11A2 mRNA] Plicamycin results in decreased expression of SLC11A2 mRNA
|
CTD |
PMID:23814049 |
|
NCBI chr 7:133,381,878...133,429,921
Ensembl chr 7:133,381,878...133,418,941
|
|
| G
|
Slc40a1
|
solute carrier family 40 member 1
|
decreases expression multiple interactions
|
EXP
|
Plicamycin results in decreased expression of SLC40A1 mRNA Plicamycin inhibits the reaction [cobaltous chloride results in increased expression of SLC40A1 mRNA]
|
CTD |
PMID:23814049 |
|
NCBI chr 9:55,525,457...55,633,463
Ensembl chr 9:55,525,532...55,543,460
|
|
| G
|
Sp1
|
Sp1 transcription factor
|
decreases activity multiple interactions decreases expression
|
ISO EXP
|
Plicamycin results in decreased activity of SP1 protein [Plicamycin inhibits the reaction [SP1 protein binds to TNFSF10 promoter]] which results in increased expression of TNFSF10 protein; [Plicamycin results in decreased activity of SP1 protein] inhibits the reaction [cobaltous chloride results in increased expression of DDIT4 mRNA]; [Plicamycin results in decreased activity of SP1 protein] inhibits the reaction [cobaltous chloride results in increased expression of DDIT4 protein]; Plicamycin inhibits the reaction [SP1 protein binds to CDKN1A promoter]; Plicamycin inhibits the reaction [SP1 protein binds to TNFSF10 promoter] Plicamycin results in decreased expression of SP1 mRNA Plicamycin results in decreased expression of SP1 protein
|
CTD |
PMID:15946989 PMID:17307335 PMID:21603612 PMID:23814049 PMID:24244623 PMID:34087332 More...
|
|
NCBI chr 7:135,419,864...135,450,513
Ensembl chr 7:135,420,050...135,450,513
|
|
| G
|
Tfrc
|
transferrin receptor
|
increases expression
|
EXP
|
Plicamycin results in increased expression of TFRC mRNA
|
CTD |
PMID:23814049 |
|
NCBI chr11:81,668,478...81,690,318
Ensembl chr11:81,668,478...81,690,318
|
|
| G
|
Tgfb1
|
transforming growth factor, beta 1
|
multiple interactions
|
EXP
|
Plicamycin inhibits the reaction [AGT protein results in increased expression of TGFB1 mRNA]
|
CTD |
PMID:25398788 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
| G
|
Tnfsf10
|
TNF superfamily member 10
|
multiple interactions
|
ISO
|
[Plicamycin inhibits the reaction [SP1 protein binds to TNFSF10 promoter]] which results in increased expression of TNFSF10 protein; Plicamycin inhibits the reaction [SP1 protein binds to TNFSF10 promoter]
|
CTD |
PMID:21603612 |
|
NCBI chr 2:112,136,550...112,155,903
|
|
| G
|
Tnip1
|
TNFAIP3 interacting protein 1
|
decreases expression
|
ISO
|
Plicamycin results in decreased expression of TNIP1 mRNA
|
CTD |
PMID:23464785 |
|
NCBI chr10:39,537,759...39,585,038
Ensembl chr10:39,537,437...39,585,158
|
|
| G
|
Xrcc1
|
X-ray repair cross complementing 1
|
decreases expression
|
ISO
|
Mithramycin A decreases expression of XRCC1 mRNA in lung and liver cancer and liver cancer cell lines
|
RGD |
PMID:30088263 |
RGD:15036795 |
NCBI chr 1:89,268,721...89,296,619
Ensembl chr 1:89,268,644...89,296,613
|
|